Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Presentation crawled time : 15:00 save search
UPDATE: New Aurinia Presentation Details at the 2024 Bloom Burton & Co. Healthcare Investor Conference
Published: 2024-04-16 (Crawled : 15:00) - ir.auriniapharma.com
AUPH | $5.01 4.16% 3.99% 1.6M
|
Health Technology
|
| O: -0.6%
H: 1.4%
C: -0.2%
conference presentation
Blacksmith Medicines Announces Upcoming Presentation at AACR Annual Meeting 2024
Published: 2024-03-06 (Crawled : 15:00) - prnewswire.com
CYT | $3.02 2.65% 1M
|
Manufacturing
|
| O: 0.0%
H: 0.65%
C: -0.65%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.86%
H: 0.45%
C: -0.58%
presentation meeting
Omeros Corporation Announces Upcoming Presentation Detailing Narsoplimab Compassionate Use in Nine Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy
Published: 2024-02-20 (Crawled : 15:00) - biospace.com/
OMER | $3.045 -5.14% -5.42% 390K
|
Health Technology
|
| O: -1.64%
H: 2.08%
C: -3.12%
presentation corporation cell
NorthView Acquisition Files Investor Presentation on $416M Profusa Deal
Published: 2024-01-29 (Crawled : 15:00) - spacfeed.com
BFRG | $2.71 -10.27% -11.44% 130K
|
n/a
|
| O: -12.93%
H: 1.14%
C: -3.43%
presentation acquisition deal
Adaptimmune Projects Sarcoma Franchise to Deliver US Peak Year Sales up to $400 Million - Presentation at JP Morgan Healthcare Conference
Published: 2024-01-04 (Crawled : 15:00) - biospace.com/
ADAP | $0.97 7.97% 7.38% 1.5M
|
Health Technology
|
| O: 5.34%
H: 11.7%
C: 6.71%
sales conference year presentation million
Intensity Therapeutics Selected for Spotlight Oral Presentation at the 2023 San Antonio Breast Cancer Symposium
Published: 2023-12-01 (Crawled : 15:00) - biospace.com/
INTS | $3.93 3.15% 3.05% 5.1K
|
|
| O: 0.39%
H: 33.74%
C: 28.05%
breast symposium presentation cancer therapeutics
Protara Therapeutics Announces Presentation of Additional Encouraging Data from Phase 1a ADVANCED-1 Trial of TARA-002 in NMIBC at the 24th Annual Meeting of the Society of Urologic Oncology
Published: 2023-11-30 (Crawled : 15:00) - biospace.com/
TARA | $2.62 -4.73% -4.96% 210K
|
Health Technology
|
| O: -2.01%
H: 4.71%
C: -0.68%
tara-002 presentation meeting trial therapeutics
Ocuphire Pharma Announces Presentation at Ophthalmology Innovation Summit (OIS) XIIIInvestor Call with CEO, George Magrath, M.D., M.B.A., M.S. on December 5, 2023
Published: 2023-11-30 (Crawled : 15:00) - biospace.com/
OCUP | $1.66 -0.6% -0.6% 230K
|
Health Technology
|
| O: 3.28%
H: 8.48%
C: 7.77%
pharma presentation innovation
AbelZeta Announces Two Abstracts Accepted for Presentation at the 65th ASH Annual Meeting
Published: 2023-11-22 (Crawled : 15:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.92%
H: 0.0%
C: 0.0%
presentation meeting
Rallybio Announces Acceptance of FNAIT Natural History Study Abstract for Presentation at the 65th American Society of Hematology Annual Meeting
Published: 2023-11-02 (Crawled : 15:00) - biospace.com/
RLYB | News | $1.75 4.79% 4.57% 310K
|
|
| O: 0.0%
H: 5.2%
C: -2.84%
natural presentation meeting study
TG Therapeutics Announces Presentation of Data for BRIUMVI at the 2023 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting
Published: 2023-10-11 (Crawled : 15:00) - globenewswire.com
TGTX | $13.79 -1.43% -1.45% 3.7M
|
Health Technology
|
| O: 2.97%
H: 1.7%
C: -4.46%
briumvi presentation sclerosis treatment research meeting therapeutics
Kiora Pharmaceuticals Webcasts Its Investor Presentation from the H.C. Wainwright 3rd Annual Ophthalmology Virtual Conference
Published: 2023-08-16 (Crawled : 15:00) - biospace.com/
KPRX | $0.502 -1.57% -1.59% 49K
|
Manufacturing
|
| O: -1.4%
H: 3.32%
C: 1.48%
conference presentation pharmaceuticals
Corner Growth Acquisition Files Investor Presentation on $800M Noventiq Deal
Published: 2023-06-14 (Crawled : 15:00) - spacfeed.com
FATP | $10.915 -0.14% 8.2K
|
n/a
|
| O: -0.56%
H: 0.28%
C: 0.09%
presentation acquisition deal growth
Allogene Therapeutics Announces Encore Presentation of Phase 1 Data from the ALLO-501/501A Trials in Large B Cell Lymphoma at the European Hematology Association (EHA) Hybrid Congress
Published: 2023-05-11 (Crawled : 15:00) - globenewswire.com
ALLO | $3.48 0.58% 0.57% 2M
|
Health Technology
|
| O: 0.31%
H: 0.47%
C: -3.13%
allo-501 association presentation cell trials therapeutics
Immutep Announces Presentation of New TACTI-002 Data at the 2023 ASCO Annual Meeting
Published: 2023-04-26 (Crawled : 15:00) - biospace.com/
IMMP | $2.25 2.27% 2.22% 90K
|
Health Technology
|
| O: 3.01%
H: 1.89%
C: -4.09%
tacti-002 presentation asco meeting
Novocure Announces Presentation of Results of the LUNAR Phase 3 Clinical Trial in Non-Small Cell Lung Cancer at 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2023-04-26 (Crawled : 15:00) - biospace.com/
NVCR | $12.09 0.33% 0.33% 850K
|
Health Technology
|
| O: 0.26%
H: 7.67%
C: 4.81%
lung presentation cancer cell meeting trial results
Geron Announces Upcoming Oral Presentation at 2023 American Society of Clinical Oncology Annual Meeting of Imetelstat Data from IMerge Phase 3 Lower Risk MDS Trial
Published: 2023-04-26 (Crawled : 15:00) - biospace.com/
GERN | $3.69 -1.07% -1.08% 8.2M
|
Health Technology
|
| O: -1.24%
H: 2.51%
C: 1.67%
presentation risk meeting trial
Zai Lab Announces Presentation of Results of the LUNAR Phase 3 Clinical Trial in Non-Small Cell Lung Cancer at 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2023-04-26 (Crawled : 15:00) - globenewswire.com
ZLAB | $14.08 -0.99% -0.99% 470K
|
Health Technology
|
| O: 2.65%
H: 1.91%
C: -2.78%
NVCR | $12.09 0.33% 0.33% 850K
|
Health Technology
|
| O: 0.26%
H: 7.67%
C: 4.81%
lung presentation cancer cell meeting trial results
Kiora Pharmaceuticals Initiates Phase 2 Trial of KIO-101 for the Treatment of Ocular Presentation of Autoimmune Diseases
Published: 2023-04-17 (Crawled : 15:00) - biospace.com/
KPRX | $0.502 -1.57% -1.59% 49K
|
Manufacturing
|
| O: -1.25%
H: 0.0%
C: -1.22%
kio-101 ocular presentation treatment pharmaceuticals trial phase 2
BioVie Announces Data Abstracts from NE3107 Phase 2 Trials Accepted for Presentation at AAN 2023
Published: 2023-04-17 (Crawled : 15:00) - biospace.com/
BIVI | $0.4874 -0.21% -0.21% 490K
|
Health Technology
|
| O: -0.5%
H: 9.1%
C: -1.64%
ne3107 presentation trials phase 2
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.